Search Results
168 results
Your search is now limited to «Gene Therapy» expert search.
PR Newswire 03/20/2019 10:00
This novel gene therapy approach turns the patient's own pleural cavity cells into multiple interferon microfactories, enhancing the body's natural defences against the cancer.
More from PR Newswire:
EurekAlert 03/20/2019
Previously, Montclare had developed a protein-lipid system capable of carrying not only small-molecule therapeutic drugs but nucleic acids for gene therapy at the same time, as a dual payload, in order to treat cancer, diabetes, and other conditions requiring a variety of therapeutic approaches.
The gene therapy market is segmented based on type as, somatic gene therapy and germline gene therapy.
More from Middle East North Africa Financial Network (MENAFN):
Vycellixs scientific discoveries coupled with a portfolio of small molecule & RNA modulators address current limitations for cell & gene therapies, including the need to accelerate speed of production, lower costs, ensure end-cell viability and persistence, and improve patient outcomes.
More from Global Banking & Finance Review:
Business Wire 03/15/2019 08:10
Vycellix’s scientific discoveries coupled with a portfolio of small molecule & RNA modulators address current limitations for cell & gene therapies, including the need to accelerate speed of production, lower costs, ensure end-cell viability and persistence, and improve patient outcomes.
More from Business Wire:
Healio News 03/14/2019 11:28
Rosenberg developed the first effective gene therapies and immunotherapies for certain patients with advanced cancer, and he was the first person to successfully insert genetically modified T cells into humans.
More from Healio News:
MedCity News 03/13/2019 13:45
A British cell and gene therapy company is partnering up with the world’s largest software company to improve gene therapy vectors using cloud computing and machine learning.
More from MedCity News:
Benzinga 03/11/2019 08:00
TEL AVIV, Israel, March 11, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announces that the company will present data on its Phase 3 candidate VB-111, at the SGO 50 th Annual Meeting on Women's Cancer , to be held March 16 - 19, 2019 at the Hawaii Convention Center in Honolulu, Hawaii. Presentation Details:. Abstract:. Ofranergene Obadenovec (VB-111), an anti-cancer gene therapy, induces immunotherapeutic effect in platinum resistant ovarian cancer: histopathology findings. Session title:. Poster Day 2. Date:. Monday, March 18, 2019. Time:. 15:30 - 17:00 PM Hawaii Standard Time. Poster #:. 202.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications